0:00
12:15
The utility of prostate-specific antigen (PSA) screening for prostate cancer detection is impacted by detection of cancers with low risk of mortality. Editorialist Jeffrey J. Tosoian, MD, MPH, discusses a pragmatic approach to prostate cancer screening with JAMA Deputy Editor Mary L. (Nora) Disis, MD.
Related Content:
Mais episódios de "JAMA Author Interviews"
Não percas um episódio de “JAMA Author Interviews” e subscrevê-lo na aplicação GetPodcast.